NCT05578066 is a NA clinical trial of Developing teams of Local Leaders in Mental Health, sponsored by Pontificia Universidad Catolica de Chile.

Who is sponsoring NCT05578066?

NCT05578066 is sponsored by Pontificia Universidad Catolica de Chile.

What drugs are being tested in NCT05578066?

Interventions in NCT05578066: Developing teams of Local Leaders, Analysis of Internal Policies, Procedures and Protocols, Raising Awareness, Innovative Contact-Based Education, Recovery-Based Arts.

What condition does NCT05578066 study?

NCT05578066 studies Mental Health, Substance Abuse, Stigmatization.

Is NCT05578066 still recruiting?

NCT05578066 is currently status unknown. Last updated 13 October 2022.

Last reviewed 2022-10-13 · How we verify

NCT05578066

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Reducing Stigma Toward Mental Illness and Substance Use Issues in Primary Health Care in Chile

Status unknown NA Last updated 13 October 2022

What this trial tests

NA trial testing Developing teams of Local Leaders in Mental Health in 16 participants. Status unknown.

Timeline

1 April 2020

Primary endpoint
31 July 2024

31 March 2025

Quick facts

Lead sponsor	Pontificia Universidad Catolica de Chile
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	16
Start date	1 April 2020
Primary completion	31 July 2024
Estimated completion	31 March 2025
Sites	1 location across Chile

Drugs / interventions tested

Developing teams of Local Leaders
Analysis of Internal Policies, Procedures and Protocols
Raising Awareness
Innovative Contact-Based Education
Recovery-Based Arts

Conditions studied

Mental Health — all drugs for Mental Health →
Substance Abuse — all drugs for Substance Abuse →
Stigmatization — all drugs for Stigmatization →

Sponsor

Pontificia Universidad Catolica de Chile — full company profile →

Who can join

18 and older, any sex, with Mental Health or Substance Abuse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research project aims to determine the effectiveness of a comprehensive anti-stigma intervention in reducing stigmatizing attitudes and behaviours among Primary Health Care (PHC) providers toward individuals with mental illness and/or substance use issues (MISUI) in the Chilean context, using Centros de de Salud Familiar (CESFAMs) as the point of intervention.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Reducing stigma toward mental illness and substance use issues in primary health care in Chile: Protocol of a cluster controlled trial study.
Sapag JC, Traub C, Velasco PR, Arratia T, et al · · 2022 · cited 4× · PMID 36606131 · DOI 10.3389/fpsyt.2022.1083042

Verify or expand the search:

Other recruiting trials for Mental Health

Currently open trials in the same condition.

NCT06375551 — K-ORCA: Testing a Decision Support Tool and Group Process for Selecting Interventions · NA · recruiting
NCT07466563 — Testing Multi-level Scale-Up Strategies: Ugandan School System · NA · recruiting
NCT07073963 — Virtual Patient Groups for Sarcoidosis Associated Fatigue · NA · recruiting
NCT07494110 — Aurora: AI-Based Narrative Intervention to Support Emotional Well-Being in Clinical and Non-Clinical Populations · NA · recruiting
NCT07494786 — Palestinian ParentText for Crisis · NA · recruiting

Other Pontificia Universidad Catolica de Chile trials

Trials by the same sponsor.

NCT07396129 — Assessing the Efficacy of a High-Dose Lidocaine-Tetracaine Cream for the Treatment of Peripheral Neuropathic Pain · Phase 1, PHASE2 · not yet recruiting
NCT07510425 — Artificial Intelligence vs. Automated Messaging for Continuous Regional Analgesia Follow-up · NA · not yet recruiting
NCT07380451 — Modular Intervention for Depression Study · NA · not yet recruiting
NCT07324499 — Effect of Dexamethasone on Plasma Levels of Bupivacaine and Dexamethasone After a Single-injection Interscalene Nerve Bl · NA · not yet recruiting
NCT07330947 — Incidence and Risk Factors of Postoperative Chronic Pain in Patients Who Have Undergone Hallux Valgus Surgery · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05578066 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pontificia Universidad Catolica de Chile
Last refreshed: 13 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05578066.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing